CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PROVE project investigates how low oxygen levels, or hypoxia, contribute to the formation of blood clots in individuals at risk of venous thromboembolism. By studying immune responses and specific cell-derived particles, the project aims to enhance diagnostic and treatment strategies for this serious health conditi…
Venous thromboembolism (VTE) is a common, deadly condition affecting more than 1 million europeans, with 500.000 related deaths in EU per year.
Many risk factors are established, but it is not known what triggers a VTE event, which hampers development of predictive and therapeutic measures.
Hypoxia is known to play a major role in thrombus formation, but via which mechanisms is unclear. PROVE will be conducted at the university of Tromsø, using state-of-the-art equipment in a world-class thrombo…
UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
